Cargando…
Proton Pump Inhibitors Diminish Barrett’s Esophagus Length: Our Experience
AIM: Our main objectives were to evaluate the influence of two-year proton pump inhibitors (PPI) therapy in patients with Barrett’s oesophagus on its length, in both types, short and long segment. METHODS: In this single-centre, prospective interventional controlled study were analysed data collecte...
Autores principales: | Gashi, Zaim, Bahtiri, Elton, Gashi, Arjeta, Sherifi, Fadil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026409/ https://www.ncbi.nlm.nih.gov/pubmed/29983798 http://dx.doi.org/10.3889/oamjms.2018.232 |
Ejemplares similares
-
The Prevalence of Helicobacter Pylori Infection in Patients with Reflux Esophagitis – Our Experience
por: Gashi, Zaim, et al.
Publicado: (2013) -
What are Predictive Factors for Developing of Barrett’s Esophagus in Patients with Gerd–our Experience
por: Gashi, Zaim, et al.
Publicado: (2011) -
Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
por: Alsalahi, Omran, et al.
Publicado: (2015) -
Endoscopic Removal of a Giant Complicated Hyperplastic Gastric Polyp
por: Gashi, Zaim, et al.
Publicado: (2017) -
Anatomic Variations of Pancreaticobiliary Union
por: Sherifi, Fadil, et al.
Publicado: (2018)